Gene therapy research in developing world raises ethical red flags: experts

Early stage gene therapy clinical trials are recruiting patients from the developing world, providing medically deprived populations access to interventions that show promise but have largely unknown effects in humans. According to commentary by bioethicists at Carnegie Mellon and McGill universities published in this week's issue of The Lancet, the practice may be inconsistent with international ethics guidelines on justice.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news134844850.html">Gene therapy research in developing world raises ethical red flags: experts</a></p> <p>Early stage gene therapy clinical trials are recruiting patients from the developing world, providing medically deprived populations access to interventions that show promise but have largely unknown effects in humans. According to commentary by bioethicists at Carnegie Mellon and McGill universities published in this week's issue of The <I>Lancet,</I> the practice may be inconsistent with international ethics guidelines on justice.</p>